Clinical Trial

A Clinica Study of SCTC21C in Participants With Systemic Lupus Erythematosus

Name: A Clinica Study of SCTC21C in Participants With Systemic Lupus Erythematosus — clinical trial record (NCT07538154)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of SCTC21C in participants with systemic lupus erythematosus

Trial Details

NCT Number	NCT07538154
Lead Sponsor	Sinocelltech Ltd.
Conditions	Systemic Lupus Erythematosus (SLE)
Enrollment	159 participants
Start Date	2026-04
Primary Completion	2027-04 (estimated)
Study Completion	2028-04 (estimated)
Updated on ClinicalTrials.gov	2026-04-20